Form D Explorer

Inspect source fieldsReport a record issue

Form D/A — Auron Therapeutics, Inc.

0001746139-25-000003 · filed Dec 23, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$42,289,180
Reported amount sold
$27,289,180
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Auron Therapeutics, Inc.
CIK
1746139
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
1 Grove Street
Wellesley, Massachusetts 02482-9998
Phone
310-922-5881

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗